Log in

NASDAQ:OGIOrganiGram Stock Price, Forecast & News

$1.87
+0.18 (+10.65 %)
(As of 05/28/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.68
Now: $1.87
$1.98
50-Day Range
$1.17
MA: $1.57
$1.84
52-Week Range
$1.09
Now: $1.87
$7.88
Volume15.43 million shs
Average Volume4.62 million shs
Market Capitalization$328.56 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
OrganiGram Holdings Inc., through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders. OrganiGram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 4.3Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.62 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:OGI
CUSIPN/A
CIKN/A
Phone1-855-961-9420

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$61.27 million
Cash Flow$0.11 per share
Book Value$1.58 per share

Profitability

Net Income$-7,200,000.00

Miscellaneous

Employees615
Market Cap$328.56 million
Next Earnings Date7/20/2020 (Estimated)
OptionableNot Optionable

Receive OGI News and Ratings via Email

Sign-up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.

OrganiGram (NASDAQ:OGI) Frequently Asked Questions

How has OrganiGram's stock been impacted by COVID-19 (Coronavirus)?

OrganiGram's stock was trading at $1.72 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, OGI shares have increased by 8.7% and is now trading at $1.87. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of OrganiGram?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last year. There are currently 6 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for OrganiGram.

When is OrganiGram's next earnings date?

OrganiGram is scheduled to release its next quarterly earnings announcement on Monday, July 20th 2020. View our earnings forecast for OrganiGram.

How were OrganiGram's earnings last quarter?

OrganiGram Holdings Inc (NASDAQ:OGI) issued its earnings results on Tuesday, April, 14th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The business had revenue of $27.30 million for the quarter, compared to analysts' expectations of $25.07 million. OrganiGram had a negative net margin of 45.14% and a negative return on equity of 5.33%. The company's quarterly revenue was down 18.3% compared to the same quarter last year. View OrganiGram's earnings history.

What price target have analysts set for OGI?

12 brokers have issued 1-year target prices for OrganiGram's stock. Their forecasts range from $1.72 to $12.00. On average, they expect OrganiGram's stock price to reach $6.46 in the next year. This suggests a possible upside of 245.5% from the stock's current price. View analysts' price targets for OrganiGram.

Has OrganiGram been receiving favorable news coverage?

Media stories about OGI stock have been trending neutral recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. OrganiGram earned a media sentiment score of 0.1 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next several days. View the latest news aboutOrganiGram.

Are investors shorting OrganiGram?

OrganiGram saw a increase in short interest in April. As of April 30th, there was short interest totaling 12,120,000 shares, an increase of 33.5% from the April 15th total of 9,080,000 shares. Based on an average daily volume of 3,748,600 shares, the days-to-cover ratio is currently 3.2 days. Currently, 7.1% of the company's stock are short sold. View OrganiGram's Current Options Chain.

Who are some of OrganiGram's key competitors?

What other stocks do shareholders of OrganiGram own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Cronos Group (CRON), KushCo (KSHB), Aphria (APHA), Auxly Cannabis Group (CBWTF), Charlotte's Web (CWBHF), Innovative Industrial Properties (IIPR), NVIDIA (NVDA) and Alibaba Group (BABA).

Who are OrganiGram's key executives?

OrganiGram's management team includes the following people:
  • Mr. Greg Engel, CEO & Director (Age 54)
  • Mr. Paolo De Luca C.A., C.F.A, Chief Financial Officer (Age 46)
  • Mr. Jeff Purcell, VP - Operations
  • Mr. Timothy Emberg, Sr. VP of Sales & Commercial Operations
  • Mr. Peter R. Hanson, Director of Fin.

What is OrganiGram's stock symbol?

OrganiGram trades on the NASDAQ under the ticker symbol "OGI."

Who are OrganiGram's major shareholders?

OrganiGram's stock is owned by a number of retail and institutional investors. Top institutional investors include ETF Managers Group LLC (6.72%), AdvisorShares Investments LLC (0.48%), Intact Investment Management Inc. (0.34%), CIBC World Markets Inc. (0.10%), Morgan Stanley (0.09%) and Jane Street Group LLC (0.08%).

Which major investors are selling OrganiGram stock?

OGI stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, CIBC World Markets Inc., Toronto Dominion Bank, Creative Planning, and Raymond James & Associates.

Which major investors are buying OrganiGram stock?

OGI stock was acquired by a variety of institutional investors in the last quarter, including ETF Managers Group LLC, Intact Investment Management Inc., Jane Street Group LLC, AdvisorShares Investments LLC, Advisor Group Holdings Inc., Sigma Planning Corp, Mission Wealth Management LP, and Mission Wealth Management LP.

How do I buy shares of OrganiGram?

Shares of OGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is OrganiGram's stock price today?

One share of OGI stock can currently be purchased for approximately $1.87.

How big of a company is OrganiGram?

OrganiGram has a market capitalization of $328.56 million and generates $61.27 million in revenue each year. The company earns $-7,200,000.00 in net income (profit) each year or $0.06 on an earnings per share basis. OrganiGram employs 615 workers across the globe.

What is OrganiGram's official website?

The official website for OrganiGram is www.organigram.ca.

How can I contact OrganiGram?

OrganiGram's mailing address is 35 English Dr., Moncton Z4, E1E 3X3. The company can be reached via phone at 1-855-961-9420.

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.